MOVE - EUROPE 2026

Description

The World Orphan Drug Congress Europe is the largest and most established European event dedicated to rare diseases and orphan drugs. It brings together the entire ecosystem, including pharmaceutical and biotech companies, government bodies, payers, patient groups, and investors. The congress focuses on the most pressing challenges in the industry, including clinical development, manufacturing, commercialization, and patient access. By fostering collaboration across the rare disease community, the event aims to accelerate the delivery of life-saving therapies to patients with unmet medical needs.

Exhibits

Showcases from leading biotech firms, CROs, CDMOs, and technology providers offering innovative solutions for rare disease drug development and patient monitoring.

Activities

Strategic keynote sessions, specialized tracks on cell and gene therapy, market access workshops, roundtable discussions, and extensive networking sessions.

Speakers

Executives from top biopharma companies, regulatory officials from EMA and FDA, patient advocacy leaders, and academic researchers in the rare disease field.

Demos

Live presentations of digital health platforms, advanced diagnostic tools, and new data management systems designed for small-population clinical trials.

Accessibility

The event is typically held at major European hubs like the Fira Barcelona or similar venues. From the nearest international airport, use airport shuttles, metro lines, or taxis directly to the venue.

Exhibitor Count

150

Expected Attendance

1500

You must be logged in to comment on this event.